These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 30839510)

  • 21. Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
    Takayanagi T; Forrester SJ; Kawai T; Obama T; Tsuji T; Elliott KJ; Nuti E; Rossello A; Kwok HF; Scalia R; Rizzo V; Eguchi S
    Hypertension; 2016 Oct; 68(4):949-955. PubMed ID: 27480833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-(1-7) attenuates hypertension in exercise-trained renal hypertensive rats.
    Shah A; Oh YB; Lee SH; Lim JM; Kim SH
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(11):H2372-80. PubMed ID: 22467306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central CYP1B1 (Cytochrome P450 1B1)-Estradiol Metabolite 2-Methoxyestradiol Protects From Hypertension and Neuroinflammation in Female Mice.
    Singh P; Song CY; Dutta SR; Gonzalez FJ; Malik KU
    Hypertension; 2020 Apr; 75(4):1054-1062. PubMed ID: 32148125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of nonfibrotic left ventricular hypertrophy in an ANG II-induced chronic ovine hypertension model.
    Klatt N; Scherschel K; Schad C; Lau D; Reitmeier A; Kuklik P; Muellerleile K; Yamamura J; Zeller T; Steven D; Baldus S; Schäffer B; Jungen C; Eickholt C; Wassilew K; Schwedhelm E; Willems S; Meyer C
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27613823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.
    Potthoff SA; Stamer S; Grave K; Königshausen E; Sivritas SH; Thieme M; Mori Y; Woznowski M; Rump LC; Stegbauer J
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27407119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal sympathetic denervation attenuates hypertension and vascular remodeling in renovascular hypertensive rats.
    Li P; Huang PP; Yang Y; Liu C; Lu Y; Wang F; Sun W; Kong XQ
    J Appl Physiol (1985); 2017 Jan; 122(1):121-129. PubMed ID: 27742806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
    Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines.
    Kang YM; Zhang DM; Yu XJ; Yang Q; Qi J; Su Q; Suo YP; Yue LY; Zhu GQ; Qin DN
    Toxicol Appl Pharmacol; 2014 Feb; 274(3):436-44. PubMed ID: 24342267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats.
    Wu R; Laplante MA; De Champlain J
    J Hypertens; 2004 Apr; 22(4):793-801. PubMed ID: 15126922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension.
    Stevenson KM; Edgley AJ; Bergström G; Worthy K; Kett MM; Anderson WP
    Hypertension; 2000 Nov; 36(5):839-44. PubMed ID: 11082153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency.
    Yagi S; Aihara K; Ikeda Y; Sumitomo Y; Yoshida S; Ise T; Iwase T; Ishikawa K; Azuma H; Akaike M; Matsumoto T
    Circ Res; 2008 Jan; 102(1):68-76. PubMed ID: 17967781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats.
    Mori T; Cowley AW
    Hypertension; 2004 Apr; 43(4):752-9. PubMed ID: 14981064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal denervation attenuates aldosterone expression and associated cardiovascular pathophysiology in angiotensin II-induced hypertension.
    Hong MN; Li XD; Chen DR; Ruan CC; Xu JZ; Chen J; Wu YJ; Ma Y; Zhu DL; Gao PJ
    Oncotarget; 2016 Oct; 7(42):67828-67840. PubMed ID: 27661131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.
    Erbanová M; Thumová M; Husková Z; Vanecková I; Vanourková Z; Mullins JJ; Kramer HJ; Bürgelová M; Rakusan D; Cervenka L
    J Hypertens; 2009 Mar; 27(3):575-86. PubMed ID: 19330918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.
    McCollum LT; Gallagher PE; Ann Tallant E
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(3):H801-10. PubMed ID: 22140049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
    Mercure C; Yogi A; Callera GE; Aranha AB; Bader M; Ferreira AJ; Santos RA; Walther T; Touyz RM; Reudelhuber TL
    Circ Res; 2008 Nov; 103(11):1319-26. PubMed ID: 18845809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.